zacks.com · 2 jul

Do Options Traders Know Something About Darling Ingredients Stock We Don't?

Investors need to pay close attention to DAR stock based on the movements in the options market lately.

zacks.com · 26 jun

4 Value Stocks to Buy Amid Costly AI Bets and Inflation

DAR, GPRE, TX and NEXA screen as high-earnings-yield value picks as inflation worries and AI spending fears sharpen stock selection.

zacks.com · 25 jun

4 Stocks to Buy as Online Grocery Sales Surge Amid Inflationary Woes

Online grocery sales jumped 19% in Q1 2026, putting TSN, CHEF, DAR and MAMA in focus amid rising grocery spending and high inflation.

businesswire.com · 3 jun

Darling Ingredients' Health Brand Rousselot Receives U.S. Patent for Nextida® GC, the First Collagen Peptide Composition Supporting Blood Glucose Regulation

IRVING, Texas--(BUSINESS WIRE)---- $DAR--Darling Ingredients Inc. (NYSE: DAR) and its health brand Rousselot today announced that the U.S. Patent and Trademark Office (USPTO) has granted Patent No. US12636339 for Nextida GC, a first-of-its-kind collagen peptide ingredient developed to help support healthy after-meal blood sugar levels, naturally. The patent protects both the production process and the use of Nextida GC as a dietary supplement ingredient, offering a non-pharmaceutical option for managing.

globenewswire.com · 2 jun

Nevada’s Only Refinery Just Got a Jet-Fuel Makeover Plan

WOODS CROSS, Utah, June 02, 2026 (GLOBE NEWSWIRE) -- Energy Metal News News Commentary - The U. S. refining map is getting smaller. West Coast capacity has been shrinking as older plants close, the major refiners spent the first quarter of 2026 emphasizing discipline over expansion, and the Trump administration has used Defense Production Act determinations to flag domestic refining as a strategic priority.

zacks.com · 27 may

Darling Ingredients vs. Tyson Foods: Which Stock Stands Out?

DAR and TSN showcase contrasting food industry models as sustainability, protein demand and operational execution shape growth paths.

seekingalpha.com · 27 may

Darling Ingredients: The Recovery Is Visible

Darling Ingredients (DAR) is rated Buy, supported by a visible earnings recovery, improved margins, and a compelling forward valuation versus peers. Q1 2026 delivered sharply higher EBITDA ($406.8M), gross margin expansion to 26.1%, and a return to profitability, signaling the roughest period is likely over. Core Feed and Food Ingredients segments drove margin and EBITDA gains without major volume growth, while DGD's Q1 result was boosted by a non-recurring inventory benefit.

zacks.com · 25 may

Is Darling Ingredients Entering a New Strategic Growth Phase?

DAR shifts focus toward cash flow, operational efficiency and balance-sheet flexibility as renewable fuels conditions improve.